Related Experiment Videos
Maintenance treatment with antidepressants in panic disorder
The Journal of Clinical Psychiatry
|December 1, 1990
Summary
Long-term antidepressant use for panic disorder is often necessary but carries significant risks. More research is crucial to balance the benefits and dangers of these essential panic disorder treatments.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Panic disorder is a chronic condition often necessitating long-term pharmacologic treatment.
- The long-term benefits and risks of antidepressant therapy for panic disorder remain understudied.
Purpose of the Study:
- To review the effectiveness and risks associated with long-term antidepressant use in panic disorder management.
- To inform patients and clinicians about the need for careful consideration of risks versus benefits.
Main Methods:
- Literature review of studies on antidepressant efficacy and safety in panic disorder.
- Analysis of risks associated with tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs).
Main Results:
- TCAs and MAOIs are effective for panic disorder, but relapse is common upon discontinuation, necessitating maintenance treatment.
- Long-term use of TCAs and MAOIs poses risks, including fatal overdoses and hypertensive crises.
Conclusions:
- Patients require awareness of the risks and benefits of long-term antidepressant therapy.
- Strategies include dose reduction, periodic tapering, and integrating other therapies.
- Further research into the long-term effects of antidepressants for panic disorder is essential.